This is the authors' abstract. We don't add key points for this paper.
Background: There is increasing evidence that type 2 diabetes mellitus (T2D) patient has higher risk for hypervirulent Klebsiella pneumoniae (hvKP) infections. Neutrophils achieve different immunological functions such as phagocytosis, and neutrophil extracellular trap (NETs) formation to arrest and eradicate microbes such as hvKp. Physicians have restricted curative approach for treatment of infection due to these superbugs. This necessitates to more understand innate immune arm included in these infections. Objective: This study aimed to investigate in vitro interaction of human NETs (as one of innate immune components) with hvKp in T2D. Methodology: Twenty patients with T2D and twenty age and sex matched healthy persons as healthy controls (HCs) were included in this study. By using clinical-derived hvKp strains, NETs complex testing by immunofluorescence, phagocytosis detection and NETs killing analysis were performed. Results: Direct killing of diabetic patients NETs against hvKp strain significantly decreased compared to NETs of HCs despite NETosis induction was significantly higher in neutrophils of T2D patients, compared to neutrophils of HCs. HvKp showed significantly lower level of phagocytosis compared to the control strain (14.65% vs. 96.43%). However, insignificant difference in the level of phagocytosis was detected between T2D and HCs neutrophils. Conclusion: Our study suggests that impaired NETs bactericidal ability makes diabetic patient more susceptible to develop hvKp invasive infection. This will shed light on a novel NETs dependant therapeutic approach and improved therapeutic plan against hvKP infection in T2D patient.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Salama et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: